Fall Skin Care Sale

Nail Health References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Fawcett RS, Linford S et al. Nail abnormalities: Clues to systemic disease. Am Fam Physician. 2004 Mar 15;69(6):1417–24.
  2. Farber EM, Nall J. Nail psoriasis. Cutis. 1992 Sep;50(3):174–8.
  3. Gupta AK, Jain HC et al. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists’ offices in Ontario, Canada: A multicenter survey of 2001 patients. Int J Dermatol. 1997;36:783–7.
  4. Gupta AK, Jain HC et al. Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: A multicenter Canadian survey of 15,000 patients. J Am AcadDermatol. 2000;43:244–8.
  5. Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol. 2003 Sep;149(Suppl 65):1–4.
  6. Gupta AK, Konnikov N et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: A multicentre survey. Br J Dermatol. 1998;139(4):665–71.
  7. Dolan C, Hall JA et al. Photo quiz: Proximal white finger nails. Am Fam Physician. June 2004;69(12):2903–4.
  8. Kyle AA, Dahl MV. Topical therapy for fungal infections.Am J ClinDermatol. 2004;5(6):443–51.
  9. Shaw J, Body R. Best evidence topic report: Incision and drainage preferable to oral antibiotics in acute paronychial nail infection? Emerg Med J. 2005 Nov;22(11):813–4.
  10. Food and Drug Administration. http://www.fda.gov/cder/drug/advisory/sporanox-lamisil/qa.htm. Accessed July 10, 2006.
  11. Tavakkol A, Fellman S et al. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: Analysis of the elderly subgroup in Improving Results in Onychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial. Am J GeriatrPharmacother. 2006 Mar;4(1):1–13.
  12. Sikder AU, Mamun SA et al. Study of oral itraconazole and terbinafine pulse therapy in onychomycosis. Mymensingh Med J. 2006 Jan;15(1):71–80.
  13. Avner S, Nir N et al. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. J Dermatolog Treat. 2005;16(5-6):327–39.
  14. Kawada A, Aragane Y et al. Clinical and pharmacokinetic studies of continuous itraconazole for the treatment of onychomycosis. J Dermatol. 2004 Feb;31(2):104–8.
  15. Hiruma M, Matsushita A et al. One week pulse therapy with itraconazole(200 mg day-1) for onychomycosis: Evaluation of treatment results according to patient background. Mycoses. 2001 May;44(3-4):87–93.
  16. Rigopoulos D, Katoulis AC et al. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis. Br J Dermatol. 2003 Jul;149(1):151–6.
  17. Sigurgeirsson B, Olafsson JH et al. Long-term effectiveness of treatment with terbinafinevsitraconazole in onychomycosis: A 5-year blinded prospective follow-up study. Arch Dermatol. 2002;138:353–7.
  18. Tosti A, Piraccini BM et al. Relapses of onychomycosis after successful treatment with systemic antifungals: A three-year follow-up. Dermatology. 1998;197:162–6.
  19. Hay RJ. The future of onychomycosis therapy may involve a combination of approaches. Br J Dermatol. 2001;145(suppl 60):3–8.
  20. Zakeri M, Valikhani M et al. Topical calcipotriol therapy in nail psoriasis: A study of 24 cases. Dermatol Online J. 2005 Dec 1;11(3):5.
  21. Fritz K. Successful local treatment of nail psoriasis with 5-fluorourocil.Z Hautkr. 1989 Dec 15;64(12):1083–8.
  22. Iida N, Ohsumi N. Treatment of severe deformities of the toenails by the modified Zadik method with artificial skin. Scand J PlastReconstrSurg Hand Surg. 2004;38(3):155–9.
  23. Barel A, Colomme M et al. Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin. Arch Dermatol Res. 2005 Oct;297(4):147–53.
  24. Williams HC, Buffham R et al. Successful use of topical vitamin E solution in the treatment of nail changes in yellow nail syndrome. Arch Dermatol. July 1991;127:1023–8.
  25. Rommel A, Havet M et al. Syndrome des onglesjaunes: Réponse à la vitamine E. Ann DermatolVenereol. 1985;112:625–7.
  26. Venencie PY, Dicken CH. Yellow nail syndrome: Report of five cases. J Am AcadDermatol. 1984;10:187–92.
  27. Ayres S, Mihan R. Yellow nail syndrome: Response to vitamin E. Arch Dermatol. 1973;108:267–8.
  28. Floersheim GL. Treatment of brittle fingernails with biotin.Z Hautkr. 1989;64:41–8 [in German].
  29. Hochman LG, Scher RK et al. Brittle nails: response to daily biotin supplementation. Cutis. 1993 Apr;51(4):303-5.
  30. Colombo VE, Gerber F et al. Treatment of brittle fingernails and onychoschizia with biotin: Scanning electron microscopy. J Am AcadDermatol. 1990 Dec;23(6 Pt 1):1127–32.
  31. Cashman MW, Sloan SB (2010). "Nutrition and nail disease".Clinics in Dermatology 28 (4): 420–425.
  32. Hausmann M, Keller R. Yellow nail syndrome. Pneumologie. 1994 Jan;48(1):30–3.
  33. Arroyo JF, Cohen ML. Improvement of yellow nail syndrome with oral zinc supplementation.ClinExpDermatol. 1993 Jan;18(1):62–4.